Search results for "Cancer"

showing 10 items of 11546 documents

Markers for gastric cancer premalignant lesions: where do we go?

2012

Only a small proportion of patients infected with <i>Helicobacter pylori</i> develop gastric cancer during their lifetime. At the same time, this type of cancer remains an important cause of mortality globally. The current interventional strategies have not been successful in decreasing the global burden of the disease; therefore, biomarkers for the identification of the individuals at high risk as well as those in the early stage of the disease is of high importance. In addition, predicting the point of no return for the development of the malignancy is of particular interest; whether atrophy, intestinal or spasmolytic polypeptide-expressing metaplasia, or some of their subtype…

medicine.medical_specialtybiologybusiness.industryGastroenterologyMEDLINECancerGeneral MedicineHelicobacter pylorimedicine.diseasebiology.organism_classificationGastroenterologyMicroRNAsAtrophyPepsinStomach NeoplasmsInternal medicinebiology.proteinmedicineBiomarkers TumorHumansAtrophybusinessPrecancerous ConditionsEarly Detection of CancerDigestive diseases (Basel, Switzerland)
researchProduct

Testicular cancer and viral infections: A systematic literature review and meta-analysis

2013

In 1984, Newell and coworkers were the first to suggest that testicular cancer might have a viral etiology since it showed similar characteristics to Hodgkin's lymphoma. A systematic literature review and meta-analysis was conducted to investigate a possible association between viral infections (EBV, CMV, Parvovirus B19, HPV, and HIV) and testicular cancer. Articles published from 1985 through June 2010 were located from MEDLINE and EMBASE databases, 21 articles were finally included in the review. For infection with EBV, CMV, Parvovirus B19, and HIV the pooled OR were 4.80 (95% CI 0.98–23.54), 1.85 (95% CI 0.92–3.70), 2.86 (95% CI 0.35–23.17), and 1.79 (95% CI 1.45–2.21) respectively. No p…

medicine.medical_specialtybiologybusiness.industryParvovirusvirusesHPV infectionvirus diseasesmedicine.diseasebiology.organism_classificationViral IdentificationVirologyLymphomaInfectious DiseasesSystematic reviewVirologyMeta-analysisEpidemiologyMedicinebusinessTesticular cancerJournal of Medical Virology
researchProduct

Analysis of gut microbiota in advanced non-small cell lung cancer (NSCLC) patients treated with immune-checkpoints blockers

2019

Abstract Background The microbiota community is considered as an organ of the human body. Recent studies have found that dysbiosis may have an impact on the interaction between immune regulation and tumor treatment. The main objective of this study is to characterize the gut microbiota in patients with non-small cell lung cancer (NSCLC) in advanced stages, and its relationship with obesity, smoking habits, clinical pathological features and response to treatment with immune-checkpoints blockers (ICB). Methods 16S rRNA gene sequencing was performed on 48 stool samples from advanced NSCLC patients prior to treatment with ICB (PD-1 inhibitor and PD-L1 inhibitor). The database used for the taxo…

medicine.medical_specialtybiologybusiness.industrynon-small cell lung cancer (NSCLC)HematologyDiseaseGut floramedicine.diseasebiology.organism_classificationGastroenterologyOncologyInternal medicinemedicinePrevotellaAdenocarcinomaMicrobiomebusinessAlistipesDysbiosisAnnals of Oncology
researchProduct

Results of a Phase I-II Pilot Study with Intravescical Gemcitabine in Superficial Bladder Cancer (Ta-T1)

2005

To study the ablative activity of intravescical gemcitabine against superficial transitional cell carcinoma of the bladder at different doses and concentrations. Methods Twenty-seven patients were treated with intravescical gemcitabine after transurethral resection, during which one to three papillary marker lesions were left unresected. Starting 14 days after transurethral resection, six gemcitabine instillations were given at weekly intervals. Gemcitabine, diluted in 50 mL of saline solution and maintained for 2 hr, was given at a dose of 500, 1000 and 2000 mg in groups of nine patients each. A complete response (CR) was defined as negative cutologycystoscopy and biopsy findings. Results…

medicine.medical_specialtybusiness.industry030232 urology & nephrologyUrologyGeneral Medicinemedicine.diseaseGemcitabine03 medical and health sciences0302 clinical medicinePhase i iiTransitional cell carcinomaTolerability030220 oncology & carcinogenesisAblative casemedicineSuperficial bladder cancerbusinessmedicine.drugUrologia Journal
researchProduct

Appropriate cytotoxic drugs usages in solid tumors: Impact of appropriate use referentials

2012

Summary Background The appropriate use of anticancer drugs is at major stake of steering health facilities. French health authorities have specifically elaborated evidence-based principles and guidelines on good practice for the management of anticancer drugs called “referentiels de bon usage” (RBU in French). Objectives The primary aim of the survey is to confront therapeutic practices and PGU. The secondary objective is to evaluate the impact of PGU on “outside the prescribing guidelines” therapeutic use, as compared with a similar study conducted in 2004. Patients and methods The survey was conducted from 1st July 2008 to 31st March 2009 at two reference centers in cancer research, and i…

medicine.medical_specialtybusiness.industryAlternative medicineEvidence-based medicineDiseaseAppropriate useAnticancer drugScientific evidencemedicinePharmacology (medical)Prospective payment systemIntensive care medicineGood practicebusinessLe Pharmacien Hospitalier et Clinicien
researchProduct

Pharmacological Management of Cancer Pain in the Elderly

2007

Existing studies indicate a high prevalence rate and poor management of cancer pain in the elderly. Pain is often considered an expected concomitant of aging, and older patients are considered more sensitive to opioids. Despite the well known pharmacokinetic changes in the elderly, the complex network of factors involved in the opioid response make the evaluation of a single element, such as age, more difficult. Notwithstanding such difficulties, appropriate analgesic treatment is able to control cancer pain in the elderly in most cases. Skills necessary to optimise pain control in older cancer patients include the ability to objectively assess functional age (not necessarily related to chr…

medicine.medical_specialtybusiness.industryAnalgesicChronic painPainCancerAnalgesics Non-Narcoticmedicine.diseaseAnalgesics OpioidPharmacotherapyQuality of lifeOpioidChemotherapy AdjuvantNeoplasmsmedicinePhysical therapyHumansPharmacology (medical)Geriatrics and GerontologyIntensive care medicineAdverse effectbusinessCancer painAgedmedicine.drugDrugs & Aging
researchProduct

Breakthrough pain in cancer patients

2015

The aim of this article was to examine the definition, the characteristics, and the management of breakthrough cancer pain (BTP) in cancer patients by a critical review of recent literature.BTP should be more correctly defined as an episode of severe intensity in patients receiving an adequate treatment with opioids able to provide at least mild analgesia. BTP is a heterogeneous condition as episodes vary between individuals. BTP can be classified into two big distinct pictures: spontaneous-type and incident-type pain. The principal pharmacological treatment of BTP is represented by the administration of opioids as needed. Recent reviews revealed that transmucosal preparation of fentanyl pr…

medicine.medical_specialtybusiness.industryBreakthrough PainBreakthrough PainMEDLINETreatment optionsCancermedicine.diseasePain IntractableAnesthesiology and Pain MedicineNeoplasmsPrevalencemedicinePhysical therapyHumansIntensive care medicinebusinessCancer painCurrent Opinion in Anaesthesiology
researchProduct

Prevalence of Cardiac Disease in Breast Cancer Patients at Time of Diagnosis Compared to the General Female Population in Germany.

2018

<b><i>Background:</i></b> Advances in oncological therapy have significantly improved breast cancer survival; therefore comorbid conditions are becoming more relevant. We investigated the prevalence of prior cardiovascular diseases and risk factors in patients with breast cancer compared to those in the general female population in Germany. <b><i>Methods:</i></b> The PASSOS heart study is a retrospective multicenter cohort study on cardiac late effects in breast cancer patients treated between 1998 and 2008. We analyzed the frequencies of cardiac diseases and cardiovascular risk factors in patients from this cohort as documented in anesthesia …

medicine.medical_specialtybusiness.industryBreast surgerymedicine.medical_treatmentDiseasemedicine.diseaseAngina03 medical and health sciences0302 clinical medicineBreast cancerOncology030220 oncology & carcinogenesisInternal medicineCohortMedicineSurgery030212 general & internal medicineMyocardial infarctionbusinessStrokeCohort studyResearch ArticleBreast care (Basel, Switzerland)
researchProduct

The Role of Epidemiology in Cancer Risk Assessment of Nonionizing Radiation

2011

medicine.medical_specialtybusiness.industryCancer risk assessmentEpidemiologyMedicineMedical physicsbusinessNon-ionizing radiationCancer Risk Evaluation
researchProduct

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

2017

WOS: 000458034100002

medicine.medical_specialtybusiness.industryCancerAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseMean differenceCancer antigen03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMeta-analysisInternal medicineJournal ArticleMedicineSinus rhythmIn patientCardiology and Cardiovascular MedicineProspective cohort studybusinessOriginal ResearchHeart Asia
researchProduct